⌘K

Login Start Free

Home/Filings/4/0000899243-19-006328

4//SEC Filing

Lynch Thomas G 4

Accession 0000899243-19-006328

CIK 0001351288other

View on SEC.gov Company Profile

Filed

Mar 4, 7:00 PM ET

Accepted

Mar 5, 9:04 PM ET

Size

12.5 KB

Accession

0000899243-19-006328

Insider Transaction Report

Form 4

Period: 2019-03-01

GW PHARMACEUTICALS PLCGWPH

Director

Transactions

Award
Stock Options
2019-03-01+16,548→ 16,548 total
Exercise: $14.33From: 2022-03-01Exp: 2029-03-01→ Ordinary Shares (16,548 underlying)
Award
Stock Options
2019-03-01+3,144→ 3,144 total
Exercise: $0.00From: 2021-03-01Exp: 2029-03-01→ Ordinary Shares (3,144 underlying)
Award
Stock Options
2019-03-01+3,144→ 3,144 total
Exercise: $0.00From: 2020-03-01Exp: 2029-03-01→ Ordinary Shares (3,144 underlying)
Award
Stock Options
2019-03-01+3,144→ 3,144 total
Exercise: $0.00From: 2022-03-01Exp: 2029-03-01→ Ordinary Shares (3,144 underlying)

Footnotes (4)

[F1]Granted pursuant to the Issuer's Long-Term Incentive Plan.
[F2]The reported options are options to purchase American Depositary Shares of the Issuer ("ADS"). Each ADS represents twelve ordinary shares of the Issuer.
[F3]The exercise price reported is price per ordinary share converted from price per ADS ($172.01).
[F4]Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.32 U.S. Dollars as of March 1, 2019.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

GW PHARMACEUTICALS PLC

CIK 0001351288

Entity typeother

Related Parties

1

filerCIK 0001360000

Filing Metadata

Form type: 4
Filed: Mar 4, 7:00 PM ET
Accepted: Mar 5, 9:04 PM ET
Size: 12.5 KB

View on SEC.gov